EXPE vs THAR · P/E 20, rev $7.74B vs $187.4M cap
Expedia Group Inc. (EXPE) versus Tharimmune Inc. (THAR) — a side-by-side from cached financials, not a winner call.
Expedia Group Inc. (EXPE) is a travel services company listed on US.
Tharimmune Inc. (THAR) is a biotechnology company listed on NASDAQ.
Latest reported EXPE revenue for 2026-06-30 was $7.74B. Net income was $872.0M. EXPE currently screens at market cap $21.71B and trailing P/E 20.4.
THAR does not have a complete income-statement cache yet.
EXPE currently screens at market cap $21.71B and trailing P/E 20.4. THAR currently screens at market cap $187.4M.
Not investment advice. Open the EXPE and THAR stock pages for the full models.
Not investment advice.